AI
Thursday, June 29, 2006 12:02:22 AM
Thomas/NVS/ANDS,
Don't take it personally
Looking as an outsider, I feel all the deals Novartis made lately in HCV space are lousy. Instead they would have been much better off licensing VX950 when it showed excellent efficacy last year.
JMHO,
Praveen
Don't take it personally
Looking as an outsider, I feel all the deals Novartis made lately in HCV space are lousy. Instead they would have been much better off licensing VX950 when it showed excellent efficacy last year.
JMHO,
Praveen
The power of imagination makes us Infinite
Trade Smarter with Thousands
Leverage decades of market experience shared openly.
